In 2023 alone, approximately 297,790 women and 2,800 men will be diagnosed with breast cancer, and it’s estimated that up to 30 percent of patients will develop metastatic disease.
That’s why Spotlight on Metastatic Breast Cancer takes an in-depth look at the driving forces and innovations behind the latest diagnostic and treatment advances, featuring expert insights from leading clinicians and researchers dedicated to the fight against this disease.
When Breast Cancer Spreads to the Brain: Diagnosis and Treatment Strategies
When Breast Cancer Spreads to the Brain: Diagnosis and Treatment Strategies
Approaches to Utilizing Bone-targeting Therapies in mBC
Approaches to Utilizing Bone-targeting Therapies in mBC
The Role of PARP Inhibitors in Metastatic Breast Cancer
The Role of PARP Inhibitors in Metastatic Breast Cancer
Advances in Early-Stage Breast Cancer Treatment: A Recap of the NATALEE Trial
Advances in Early-Stage Breast Cancer Treatment: A Recap of the NATALEE Trial
Diving into the Efficacy & Tolerability of mBC Treatment
Diving into the Efficacy & Tolerability of mBC Treatment
Exploring Efficacy & Overall Survival in the TROPiCS-02 Trial
Exploring Efficacy & Overall Survival in the TROPiCS-02 Trial
Evaluating Landmark Clinical Data for HER2-low Breast Cancer
Evaluating Landmark Clinical Data for HER2-low Breast Cancer
Evaluating a Treatment for HER2-Positive Metastatic Breast Cancer
Evaluating a Treatment for HER2-Positive Metastatic Breast Cancer
Updates on Breast Cancer Treatment: Exploring CDK4/6 Inhibitors & Endocrine Therapy
Updates on Breast Cancer Treatment: Exploring CDK4/6 Inhibitors & Endocrine Therapy
The Emerging Role of Immunotherapy in Triple-Negative Breast Cancer
The Emerging Role of Immunotherapy in Triple-Negative Breast Cancer
Treating Metastatic Breast Cancer: Where Are We Now?
Treating Metastatic Breast Cancer: Where Are We Now?
A Look at the Therapeutic Landscape for Metastatic Breast Cancer
A Look at the Therapeutic Landscape for Metastatic Breast Cancer